As ERs and PRs could influence breast cancer prognosis, and testing the tumor for both estrogen and progesterone receptors is a standard part of a breast cancer diagnosis,24 we next analyzed whether expression of TSP50/p65 and TSP50/MMP9 were associated with these two clinical molecules in breast cancer patients (Figure 8e). This evidence concerns the gene PRSS50 and neoplasm.